Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T09:15:41.987Z Has data issue: false hasContentIssue false
  • English
  • Français

The Significance of Depression in the Prediction of Relapse in Chronic Schizophrenia

Published online by Cambridge University Press:  02 January 2018

D. A. W. Johnson
D. A. W. Johnson*
Affiliation:
University Hospital of South Manchester, Manchester M208LR
Get access Rights & Permissions [Opens in a new window]

Abstract

The prospective monitoring of two separate groups of chronically schizophrenic patients on regular depot maintenance therapy suggests that depression developing after an interval of 1 year from recovery from an acute relapse indicates a significant increase in the risk of a further relapse within 2 years, compared with depression within the first year, or no depression. Patients with such depression were more prone to relapses than other patients, despite regular medication within normal dose ranges. The results suggest that the aetiology of depression occurring in patients after 1 year in a stable mental state is different from that of depression within the first year, and in many patients, the former represents underlying schizophrenic activity prior to an early relapse.

Type
Annotation
Information
The British Journal of Psychiatry , Volume 152 , Issue 3 , March 1988 , pp. 320 - 323
Copyright
Copyright © Royal College of Psychiatrists, 1988 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM-III). Washington, DC: APA.Google Scholar
Beck, A. T., Rush, A. J., Shaw, B. F. & Emery, G. (1979) Cognitive Therapy for Depression. New York: Guilford.Google Scholar
Cutting, J. (1986) Outcome of schizophrenia: overview. In Contemporary Issues in Schizophrenia (eds Kerr, A. & Snaith, P.). London: Gaskell.Google Scholar
Feighner, J. P., Robins, E. & Guze, S. B. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.Google Scholar
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville, National Institute for Mental Health, U.S. Department of Health, Education and Welfare.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.Google Scholar
Herz, M. I. & Melville, C. (1980) Relapse in schizophrenia. American Journal of Psychiatry, 137, 801–805.Google Scholar
Hirsch, S. R. (1982) Depression ‘revealed’ in schizophrenia. British Journal of Psychiatry, 140, 421–424.Google Scholar
Johnson, D. A. W. (1976) The expectation of outcome from maintenance therapy in chronic schizophrenic patients. British Journal of Psychiatry, 128, 246–250.Google Scholar
Johnson, D. A. W. (1979) Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. British Journal of Psychiatry, 135, 524–530.Google Scholar
Johnson, D. A. W. (1981a) Epidemiological evaluation of maintenance antipsychotic treatment. In Epidemiological Impact of Psychotropic Drugs (eds Tognoni, G., Bellantuono, C. & Lader, M.). North Holland: Elsevier.Google Scholar
Johnson, D. A. W. (1981b) Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry, 139, 89–101.Google Scholar
Johnson, D. A. W. (1982) The long-acting depot neuroleptics. In Recent Advances in Clinical Psychiatry (ed. Granville-Grossman, K.). Edinburgh: Churchill Livingstone.Google Scholar
Johnson, D. A. W. & Heather, B. B. (1974) The sensitivity of the Beck Depression Inventory to change in symptomatology. British Journal of Psychiatry, 124, 184–185.Google Scholar
Johnson, D. A. W., Pasterski, G., Ludlow, J. M., Street, K. and Taylor, R. D. W. (1983). The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatrica Scandinavica, 67, 339–352.Google Scholar
Johnson, D. A. W., Ludlow, J. M., Street, K. & Taylor, R. D. W. (1987) Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia. British Journal of Psychiatry, 151, 634–638.Google Scholar
Johnstone, E. C., Frith, C. D., Gold, A. & Stevens, K. (1979) The outcome of severe acute schizophrenic illness after one year. British Journal of Psychiatry, 134, 28–33.CrossRefGoogle ScholarPubMed
Knights, A. & Hirsch, S. R. (1981) Revealed depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–811.Google Scholar
Kolakowska, T., Gelder, M. G. & Orr, M. W. (1980) Drug-related and illness-related factors in the outcome of chlorpromazine treatment: testing a model. Psychological Medicine, 10, 335–343.CrossRefGoogle ScholarPubMed
Leff, J. & Wing, J. K. (1971) Trial of maintenance therapy in schizophrenia. British Medical Journal, iii, 559–604.Google Scholar
Mandel, M. R., Severe, J. B., Schooler, N. R., Gelenberg, A. J. & Mieske, M. (1982). Development and prediction of postpsychotic depression in neuroleptic treated schizophrenics. Archives of General Psychiatry, 39, 197–203.Google Scholar
McGlashan, T. H. & Carpenter, W. T. (1976) Postpsychotic depression in schizophrenia. Archives of General Psychiatry, 33, 231–239.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799–812.Google Scholar
Schooler, N. R., Levine, J., Severe, J. B., Brauzer, B., DiMascio, A., Klerman, G. L. & Tuason, V. B. (1980) Prevention of relapse in schizophrenia: an evaluation of fluphenazine decanoate. Archives of General Psychiatry, 37, 16–24.Google Scholar
Watt, D. C., Katz, K. & Shepherd, M. (1983) The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardised clinical and social assessment. Psychological Medicine, 13, 663–670.Google Scholar
World Health Organization (1979) Schizophrenia: an international follow-up study. Chichester: John Wiley.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.